Shelby D. Reed, PhD

Shelby D. Reed, PhD
Therapeutic Area Lead, Population Health Sciences Research, DCRI

Professor in Population Health Sciences

Shelby D. Reed, PhD, is a professor in the Departments of Population Health Sciences and Medicine at Duke University’s School of Medicine. She is the director of the Center for Informing Health Decisions and therapeutic area lead for Population Health Sciences at the DCRI. She also is core faculty and a member of the executive committee for the Duke-Margolis Center for Health Policy. Reed has nearly 20 years of experience in economic evaluation, health services research, and health policy. Her research portfolio includes a broad array of trial‐based and model‐based cost‐effectiveness analyses of new and existing medical diagnostics, drugs, devices, and patient‐centered interventions.

Over the last several years, Reed has increasingly worked in the field of stated‐preference research. In 2016, she co-founded the Preference Evaluation Research (PrefER) Group at the DCRI along with Reed Johnson, and she currently serves as its director. She and the group are frequently sought to conduct stated-preference studies to inform regulatory decisions, health policy, care delivery, value assessment, and clinical decision making with applied projects spanning a wide range of therapeutic areas, including cardiology, cancer, autoimmune disorders, orthopedic surgery, endocrinology, and neurology.

Reed has published over 175 manuscripts in peer‐reviewed journals. She was the first recipient of the Bernie O’Brien New Investigator Award from the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) in 2005. She served on two international task force groups coordinated by ISPOR to develop recommendations for conducting economic evaluations alongside clinical trials and recommendations to address transferability of multinational economic evaluations. Reed also served on the editorial boards for Health Services Research (2016-2020) and Value in Health (2013-present). She served as president for ISPOR in 2017-2018 and is currently chair of the society’s Health Science Policy Council.